Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsOPHTHALMICGeneric

GARAMYCIN

GENTAMICIN SULFATE

Standard Dose
EQ 0.3% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued

Key Takeaways

  • Primary indication: Marketing status: Discontinued
  • Approval overview GARAMYCIN is listed in Drugs@FDA under application 050039 (NDA).
  • Marketing status: Discontinued Active ingredient GENTAMICIN SULFATE Form and strength SOLUTION/DROPS;OPHTHALMIC - EQ 0.3% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor SCHERING Submission history Latest submission status date: 1999-10-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview GARAMYCIN is listed in Drugs@FDA under application 050039 (NDA). Marketing status: Discontinued Active ingredient GENTAMICIN SULFATE Form and strength SOLUTION/DROPS;OPHTHALMIC - EQ 0.3% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor SCHERING Submission history Latest submission status date: 1999-10-18 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.